07 . December , 2019 - Saturday
Check todays hot topics or new products

Find a Drug: Advanced

Please Sign in or Register

All about: Fluocinonide Gel

Big Image Dosage Form: Gel

Rx only

For External Use Only - Not for Ophthalmic Use

Fluocinonide Description

The topical corticosteroids constitute a class of primarily synthetic steroids used as anti-inflammatory and antipruritic agents. Fluocinonide Gel contains Fluocinonide USP (Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-6,9-difluoro-11-hydroxy-16,17-[(1-methylethylidene)bis(oxy)]-, (6α,11β,16α)-). It has a molecular formula of C26H32F2O7 and a molecular weight of 494.53. It has the following structural formula:

Each gram contains: Fluocinonide 0.5 mg in a gel base consisting of propylene glycol, propyl gallate, edetate disodium, and Carbopol 940 with sodium hydroxide and/or hydrochloric acid added to adjust the pH. This clear, colorless vehicle is greaseless, non-staining and completely water miscible. In this formulation, the active ingredient is totally in solution.

Fluocinonide - Clinical Pharmacology

Topical corticosteroids share anti-inflammatory, antipruritic and vasoconstrictive actions.

The mechanism of anti-inflammatory activity of the topical corticosteroids is unclear. Various laboratory methods, including vasoconstrictor assays, are used to compare and predict potencies and/or clinical efficacies of the topical corticosteroids. There is some evidence to suggest that a recognizable correlation exists between vasoconstrictor potency and therapeutic efficacy in man.

Pharmacokinetics: The extent of percutaneous absorption of topical corticosteroids is determined by many factors including the vehicle, the integrity of the epidermal barrier, and the use of occlusive dressings. Topical corticosteroids can be absorbed from normal intact skin. Inflammation and/or other disease processes in the skin increase the percutaneous absorption. Occlusive dressings substantially increase the percutaneous absorption of topical corticosteroids. Thus, occlusive dressings may be a valuable therapeutic adjunct for treatment of resistant dermatoses (See DOSAGE AND ADMINISTRATION).

Once absorbed through the skin, topical corticosteroids are handled through pharmacokinetic pathways similar to systemically administered corticosteroids. Corticosteroids are bound to plasma proteins in varying degrees. Corticosteroids are metabolized primarily in the liver and are then excreted by the kidneys. Some of the topical corticosteroids and their metabolites are also excreted into the bile.

Indications and Usage for Fluocinonide

Fluocinonide Gel is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Contraindications

Fluocinonide Gel is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Precautions

General: Systemic absorption of topical corticosteroids has produced reversible hypothalamic-pituitary-adrenal (HPA) axis suppression, manifestations of Cushing's syndrome, hyperglycemia, and glucosuria in some patients.

Conditions which augment systemic absorption include the application of the more potent steroids, use over large surface areas, prolonged use, and the addition of occlusive dressings. Therefore, patients receiving a large dose of a potent topical steroid applied to a large surface area or under an occlusive dressing should be evaluated periodically for evidence of HPA axis suppression by using the urinary free cortisol and ACTH stimulation tests. If HPA axis suppression is noted, an attempt should be made to withdraw the drug, to reduce the frequency of application, or to substitute a less potent steroid.

Recovery of HPA axis function is generally prompt and complete upon discontinuation of the drug. Infrequently, signs and symptoms of steroid withdrawal may occur, requiring supplemental systemic corticosteroids.

Children may absorb proportionally larger amounts of topical corticosteroids and thus be more susceptible to systemic toxicity (See PRECAUTIONS - Pediatric Use).

If irritation develops, topical corticosteroids should be discontinued and appropriate therapy instituted.

As with any topical corticosteroid product, prolonged use may produce atrophy of the skin and subcutaneous tissues. When used on intertriginous or flexor areas, or on the face, this may occur even with short-term use.

In the presence of dermatological infections, the use of an appropriate antifungal or antibacterial agent should be instituted. If a favorable response does not occur promptly, the corticosteroid should be discontinued until the infection has been adequately controlled.

Information for Patients: Patients using topical corticosteroids should receive the following information and instructions:

  1. This medication is to be used as directed by the physician. It is for external use only. Avoid contact with the eyes.
  2. Patients should be advised not to use this medication for any disorder other than for which it was prescribed.
  3. The treated skin area should not be bandaged or otherwise covered or wrapped as to be occlusive unless directed by the physician.
  4. Patients should report any signs of local adverse reactions especially under occlusive dressing.
  5. Parents of pediatric patients should be advised not to use tight fitting diapers or plastic pants on a child being treated in the diaper area, as these garments may constitute occlusive dressings.

Laboratory Tests: The following tests may be helpful in evaluating the HPA axis suppression: Urinary free cortisol test; ACTH stimulation test.

Carcinogenesis, Mutagenesis, and Impairment of Fertility: Long-term animal studies have not been performed to evaluate the carcinogenic potential or the effect on fertility of topical corticosteroids. Studies to determine mutagenicity with prednisolone and hydrocortisone have revealed negative results.

Pregnancy:Teratogenic Effects: Pregnancy Category C. Corticosteroids are generally teratogenic in laboratory animals when administered systemically at relatively low dosage levels. The more potent corticosteroids have been shown to be teratogenic after dermal application in laboratory animals. There are no adequate and well-controlled studies in pregnant women on teratogenic effects from topically applied corticosteroids. Therefore, topical corticosteroids should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Drugs of this class should not be used extensively on pregnant patients, in large amounts, or for prolonged periods of time.

Nursing Mothers: It is not known whether topical administration of corticosteroids could result in sufficient systemic absorption to produce detectable quantities in breast milk. Systemically administered corticosteroids are secreted into breast milk in quantities not likely to have a deleterious effect on the infant. Nevertheless, caution should be exercised when topical corticosteroids are administered to a nursing woman.

Pediatric Use: Pediatric patients may demonstrate greater susceptibility to topical corticosteroid-induced HPA axis suppression and Cushing's syndrome than mature patients because of a larger skin surface area to body weight ratio.

Hypothalamic-pituitary-adrenal (HPA) axis suppression, Cushing's syndrome, and intracranial hypertension have been reported in children receiving topical corticosteroids. Manifestations of adrenal suppression in children include linear growth retardation, delayed weight gain, low plasma cortisol levels, and absence of response to ACTH stimulation. Manifestations of intracranial hypertension include bulging fontanelles, headaches, and bilateral papilledema.

Administration of topical corticosteroids to children should be limited to the least amount compatible with an effective therapeutic regimen. Chronic corticosteroid therapy may interfere with the growth and development of children.

Adverse Reactions

The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: burning, itching, irritation, dryness, folliculitis, hypertrichosis, anceiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae and miliaria.

Overdosage

Topically applied corticosteroids can be absorbed in sufficient amounts to produce systemic effects (See PRECAUTIONS).

Fluocinonide Dosage and Administration

Apply a thin film to the affected area two to four times daily depending on the severity of the condition. Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions. If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.

How is Fluocinonide Supplied

Fluocinonide Gel USP, 0.05% in

15 gram tubes, NDC 0168-0135-15
60 gram tubes, NDC 0168-0135-60

Store at controlled room temperature 15°-30°C (59°-86°F).

E. FOUGERA & CO.
a division of Altana Inc.
MELVILLE, NEW YORK 11747

I213515A
R11/98
#60


Fluocinonide (Fluocinonide)
PRODUCT INFO
Product Code 0168-0135 Dosage Form GEL
Route Of Administration TOPICAL DEA Schedule
INGREDIENTS
Name (Active Moiety) Type Strength
Fluocinonide (Fluocinonide) Active 0.5 MILLIGRAM  In 1 GRAM
propylene glycol Inactive  
propyl gallate Inactive  
edetate disodium Inactive  
Carbopol 940 Inactive  
sodium hydroxide Inactive  
hydrochloric acid Inactive  
IMPRINT INFORMATION
Characteristic Appearance Characteristic Appearance
Color Score
Shape Symbol
Imprint Code Coating
Size
PACKAGING
# NDC Package Description Multilevel Packaging
1 0168-0135-15 15 GRAM In 1 TUBE None
2 0168-0135-60 60 GRAM In 1 TUBE None

Revised: 02/2007

Recent Drug Updates at DrugIndexOnline:





acetaminophen and aspirin acetaminophen and aspirin
Generic Name: acetaminophen and aspirin (a seet oh MIN oh fen and AS prin) Brand Names: Excedrin Back & Body What is acetaminophen and aspirin? Acetaminophen is a pain reliever and fever reducer. Aspirin is in a group of drugs called salicylates (sa-LIS-il-ates). It works by reducing more...

Antivert Antivert
Some commonly used brand names are: In the U.S.— Antivert 3 Antivert/25 3 Antivert/50 3 Bonine 3 Dramamine II 3 Marezine 2 Meclicot 3 Medivert 3 In Canada— Bonamine 3 Marzine 2 Note: For quick reference, the following medicines are numbered to match the corresponding brand n more...

Atropine/Diphenoxylate Atropine/Diphenoxylate
Generic Name: Atropine/Diphenoxylate Tablets (AT-row-peen/dye-fen-OX-i-late) Brand Name: Examples include Lomotil and LonoxAtropine/Diphenoxylate is used for:Treating diarrhea. It may also be used for other conditions as determined by your doctor. Atropine/Diphenoxylate is an antidiarrheal an more...

Aztreonam Aztreonam
Pronouncation: (AZZ-TREE-oh-nam) Class: Monobactam Trade Names: Azactam - Powder for injection (lyophilized cake) 500 mg (with approximately 780 mg L-arginine per gram aztreonam) - Powder for injection (lyophilized cake) 1 g (with approximately 780 mg L-arginine per gram aztreonam) - Powder for inj more...

Lidocaine Parenteral-Local Lidocaine Parenteral-Local
Some commonly used brand names are: In the U.S.— Carbocaine 7 Carbocaine with Neo-Cobefrin 7 Chirocaine 5 Citanest Forte 8 Citanest Plain 8 Dalcaine 6 Dilocaine 6 Duranest 4 Duranest-MPF 4 Isocaine 7 L-Caine 6 Lidoject-1 6 Lidoject-2 6 Marcaine 2 Marcaine Spinal 2 Nesacaine 3 Nesacaine-MP more...

Nardil Nardil
Generic Name: Phenelzine (FEN-el-zeen) Brand Name: Nardil The risk of suicidal thinking and behavior was increased by antidepressant use in short-term studies in children and adolescents with certain psychiatric disorders. Anyone considering the use of Nardil or any other antidepressant in a ch more...

Nitroglycerin Transdermal Patches Nitroglycerin Transdermal Patches
Some commonly used brand names are: In the U.S.— Deponit 2 Minitran 2 Nitro-Bid 1 Nitrodisc 2 Nitro-Dur 2 Nitrol 1 Transderm-Nitro 2 In Canada— Minitran 2 Nitro-Dur 2 Nitrol 1 Transderm-Nitro 2 Another commonly used name for nitroglycerin is glyceryl trinitrate . Note: For q more...

Omega-3-Acid Ethyl Esters Omega-3-Acid Ethyl Esters
Generic Name: Omega-3-Acid Ethyl Esters Capsules (oh-MAY-ga 3 AS-id ETH-il ES-ters) Brand Name: LovazaOmega-3-Acid Ethyl Esters is used for:Treating patients who have very high triglyceride levels. It is used in addition to a low fat diet. Omega-3-Acid Ethyl Esters is lipid-regulating medicine more...